Dr. Reddy’s reports robust growth and strategic expansions By Investing.com Stocks November 7, 2024 Dr. Reddy’s Laboratories (NYSE: RDY), a global pharmaceutical company, announced a strong financial performance in its Q2 FY 2025 earnings…